EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases

Min Yang, Manish Mittal, A Mark Fendrick, Diana Brixner, Bruce W Sherman, Yifei Liu, Pankaj Patel, Jerry Clewell, Qing Liu, Louis P Garrison

Advances in Therapy · 2025

DOI: 10.1007/s12325-024-03076-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Therapy, 2025. Verfasst von Min Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Analysis Group, Boston, MA, USA. Hauptthemen laut MEDLINE: Formularies as Topic, Health Services Accessibility, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The healthcare system in the United States (US) is complex and often fragmented across national and regional health plans which exhibit substantial variability in benefit design and formulary policies for accessing medications. We propose an access-focused value assessment framework for formulary decision-making for medications to manage immune-mediated inflammatory diseases (IMIDs), where patients are at the center of this framework. Formulary decision-making for IMID medications can be a challenging, even daunting, task with continuously evolving and enhanced treat-to-target goals. Given the complexity of the US healthcare system, patients and their caregivers need assurance from formulary decision-makers that rapid, predictable, and sustained access to both well-established treatments and innovative therapies will be a priority, with a particular emphasis on continuity of effective care. This access-focused patient-centric (APAC) value assessment approach encompasses three "value components"-higher therapeutic goals, better health-related quality of life, and improved work productivity-the monetization of which can be derived using data from clinical trials when real-world data are yet to become available. Measures and assessment approaches are outlined to serve as a pragmatic tool for decision-makers in the US to ensure timely delivery and sustained access of clinically indicated therapies aimed to improve patient outcomes, enhance equity, and increase efficiency. Formulary decision-making for immune-mediated inflammatory diseases can be complex, as more advanced therapies are developed and approved for multiple diseases, where clinical trial endpoints may vary substantially. We introduce an access-focused patient-centric framework as a decision tool maximizing patient centricity. It focuses on improvements in three core components: therapeutic outcomes, quality of life, and work productivity. Monetization of these components provides a common metric for payers to make informed decisions, allowing timely access for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Formularies as TopicHealth Services AccessibilityInflammationHumansDecision MakingPatient-Centered CareQuality of LifeUnited States

Stichwörter der Autor:innen

Access-focused patient-centricAdvanced immune therapyHealth outcomesImmune-mediated inflammatory diseasesPopulation healthValue assessment framework

Autor:innen und Institutionen

  • Analysis Group, Boston, MA, USA.
  • University of Texas, Austin, TX, USA.
  • AbbVie, North Chicago, IL, USA. manish.mittal@abbvie.com.
  • AbbVie, 26525 North Riverwoods Blvd., Mettawa, IL, 60045, USA. manish.mittal@abbvie.com.
  • University of Michigan, Ann Arbor, MI, USA.
  • University of Utah, Salt Lake City, UT, USA.

Förderung

  • AbbVie

Zitieren

APA

Yang, M., Mittal, M., Fendrick, A. M., Brixner, D., Sherman, B. W., Liu, Y., Patel, P., Clewell, J., Liu, Q., & Garrison, L. P. (2025). An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases. Advances in Therapy. https://doi.org/10.1007/s12325-024-03076-5

Vancouver

Yang M, Mittal M, Fendrick AM, Brixner D, Sherman BW, Liu Y, et al. An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases. Advances in Therapy. 2025. doi:10.1007/s12325-024-03076-5

BibTeX
@article{Yang2025,
  author = {Yang, Min and Mittal, Manish and Fendrick, A Mark and Brixner, Diana and Sherman, Bruce W and Liu, Yifei and Patel, Pankaj and Clewell, Jerry and Liu, Qing and Garrison, Louis P},
  title = {An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases},
  journal = {Advances in Therapy},
  year = {2025},
  doi = {10.1007/s12325-024-03076-5}
}
Kostenlos starten →